SK50282011A3 - Controlled acetylsalicylic acid release combined peroral preparation and method for the production thereof - Google Patents

Controlled acetylsalicylic acid release combined peroral preparation and method for the production thereof Download PDF

Info

Publication number
SK50282011A3
SK50282011A3 SK5028-2011A SK50282011A SK50282011A3 SK 50282011 A3 SK50282011 A3 SK 50282011A3 SK 50282011 A SK50282011 A SK 50282011A SK 50282011 A3 SK50282011 A3 SK 50282011A3
Authority
SK
Slovakia
Prior art keywords
starch
composition according
acetylsalicylic acid
weight
granulate
Prior art date
Application number
SK5028-2011A
Other languages
English (en)
Slovak (sk)
Inventor
Olga Sakova
Beata Vladovicova
Anna Kabzanova
Viera Kormanova
Stefan Zoricak
Original Assignee
Zentiva, K. S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva, K. S. filed Critical Zentiva, K. S.
Priority to SK5028-2011A priority Critical patent/SK50282011A3/sk
Priority to ROA201300838A priority patent/RO130316A2/ro
Priority to UAA201315213A priority patent/UA111743C2/uk
Priority to PCT/CZ2012/000042 priority patent/WO2012159593A2/fr
Priority to CZ2013-1028A priority patent/CZ20131028A3/cs
Publication of SK50282011A3 publication Critical patent/SK50282011A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK5028-2011A 2011-05-25 2011-05-25 Controlled acetylsalicylic acid release combined peroral preparation and method for the production thereof SK50282011A3 (sk)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SK5028-2011A SK50282011A3 (sk) 2011-05-25 2011-05-25 Controlled acetylsalicylic acid release combined peroral preparation and method for the production thereof
ROA201300838A RO130316A2 (ro) 2011-05-25 2012-05-24 Formulare orală combinată cu eliberare controlată a acidului acetilsalicilic şi procedeu pentru prepararea acesteia
UAA201315213A UA111743C2 (uk) 2011-05-25 2012-05-24 Комбінована пероральна композиція з контрольованим вивільненням ацетилсаліцилової кислоти і спосіб її одержання
PCT/CZ2012/000042 WO2012159593A2 (fr) 2011-05-25 2012-05-24 Formulation orale combinée à libération contrôlée d'acide acétylsalicylique et procédé pour la préparation
CZ2013-1028A CZ20131028A3 (cs) 2011-05-25 2012-05-24 Kombinovaný perorální přípravek s řízeným uvolňováním kyseliny acetylsalicylové a způsob přípravy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SK5028-2011A SK50282011A3 (sk) 2011-05-25 2011-05-25 Controlled acetylsalicylic acid release combined peroral preparation and method for the production thereof

Publications (1)

Publication Number Publication Date
SK50282011A3 true SK50282011A3 (sk) 2013-02-04

Family

ID=46513601

Family Applications (1)

Application Number Title Priority Date Filing Date
SK5028-2011A SK50282011A3 (sk) 2011-05-25 2011-05-25 Controlled acetylsalicylic acid release combined peroral preparation and method for the production thereof

Country Status (5)

Country Link
CZ (1) CZ20131028A3 (fr)
RO (1) RO130316A2 (fr)
SK (1) SK50282011A3 (fr)
UA (1) UA111743C2 (fr)
WO (1) WO2012159593A2 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3239506A (en) * 1964-10-16 1966-03-08 Eastman Kodak Co 3-azabicyclo[3.2.2]nonane sulfonamide compounds
US4505862A (en) * 1981-04-14 1985-03-19 Bristol-Myers Company Diphenydramine dihydrogencitrate
HUT72408A (en) 1993-09-10 1996-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing tablets containing acetyl-salicylic acid
KR100955669B1 (ko) * 2007-08-13 2010-05-06 한올바이오파마주식회사 ＨＭＧ­ＣｏＡ 환원효소 저해제와 아스피린을 포함하는 복합제제 및 그의 제조방법
EP2389155A2 (fr) * 2009-01-16 2011-11-30 ADD Technologies Ltd. Comprimés à désintégration orale pour traiter la douleur

Also Published As

Publication number Publication date
RO130316A2 (ro) 2015-06-30
CZ20131028A3 (cs) 2014-01-29
UA111743C2 (uk) 2016-06-10
WO2012159593A9 (fr) 2013-03-07
WO2012159593A3 (fr) 2013-01-17
WO2012159593A2 (fr) 2012-11-29

Similar Documents

Publication Publication Date Title
CN1174745C (zh) 膜衣用作口服剂型的味道掩蔽包衣的用途
US6558704B1 (en) Process for preparing pellets containing up to 90 wt.% of a pharmaceutical active ingredient
KR20100087011A (ko) 매트릭스형 의약 고형 제제
EA001537B1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
JPS6191118A (ja) チアミン塩の顆粒，その製造法および錠剤
CA3019508A1 (fr) Preparation orale presentant une exceptionnelle aptitude a l'elution
WO2015110952A1 (fr) Compositions pharmaceutiques orales solides comprenant du ticagrelor ou un sel de ce dernier
CN100484574C (zh) 盐酸头孢他美酯分散片及其制备方法
CN103610658A (zh) 一种免疫调节剂缓释剂及其制备方法
EP2814465B1 (fr) Formule pharmaceutique à stabilité améliorée
EP2508172A1 (fr) Formulations stables et uniformes d'entecavir et procédé de préparation correspondant
KR20160002177A (ko) 오셀타미비어 유리염기를 포함하는 약학 조성물
CN106983726A (zh) 阿齐沙坦片及其制备方法
CN102349915A (zh) 一种氨酚咖敏维c制剂及其制备方法
CN105412132A (zh) 复方伊维菌素缓释颗粒剂及其制备方法
WO2017093890A1 (fr) Formulation de comprimé à base de clobazam et son procédé de préparation
CN106924205A (zh) 一种含有Baricitinib的缓释制剂
CZ22997A3 (en) Preparation of tablets of fusidic acid
SK50252011U1 (sk) Kombinovaný perorálny prípravok s riadeným uvoľňovaním kyseliny acetylsalicylovej
CN109771387A (zh) 一种硫酸氢氯吡格雷片及其制备方法
CZ20131028A3 (cs) Kombinovaný perorální přípravek s řízeným uvolňováním kyseliny acetylsalicylové a způsob přípravy
CN119868294B (zh) 一种利格列汀药物组合物及制备方法
CA3048968A1 (fr) Composition pharmaceutique orale de lurasidone et sa preparation
KR20120134545A (ko) 안정성 및 함량 균일성이 개선된 속방성 약학 조성물의 제조방법
CN107569461A (zh) 一种辛伐他汀片及其制备方法

Legal Events

Date Code Title Description
FC9A Refused patent application